Results 121 to 130 of about 23,252 (243)

Serum calcium levels after 8 weeks administration of calcium-based phosphate binders.

open access: yes, 2015
Serum calcium levels after 8 weeks administration of calcium-based phosphate binders.
Han Zhang (110653)   +5 more
core   +1 more source

Effect of a transtheoretical model-based intervention and motivational interviewing on hyperphosphatemia management via telehealth (TMT program) among hemodialysis patients during the COVID-19 pandemic

open access: yesFrontiers in Public Health
BackgroundHyperphosphatemia poses a significant risk for cardiovascular diseases and mortality in hemodialysis patients. Non-adherence to phosphate binders and a low-phosphate diet behavior contribute to this issue.
Arrom Thongsunti   +7 more
doaj   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Development tendencies of moulding and core sands [PDF]

open access: yesChina Foundry, 2011
Further development of the technology for making moulding and core sands will be strictly limited by tough requirements due to protection of the natural environment.
Stanislaw M. Dobosz1   +2 more
doaj  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with chronic kidney disease

open access: yes, 2005
An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with chronic kidney disease. Chronic kidney disease has the potential to induce sequelae that can have severe and mortal outcomes.
Friedman, Eli A.
core   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients

open access: yes, 2014
Kimberly F Farrand,1 J Brian Copley,1 Jamie Heise,1 Moshe Fridman,2 Michael S Keith,1 Lynne Poole3 1Shire, Wayne, PA, USA; 2AMF Consulting, Los Angeles, CA, USA; 3Shire, Basingstoke, UK Abstract: The purpose of this study was to conduct a retrospective ...
Farr   +6 more
core  

Home - About - Disclaimer - Privacy